$3.90
▼ -0.5% Today
as of Jul 22, 09:08 ET
Last 30 days
Recent Press Releases & News
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Plus Therapeutics, Genomic Testing Cooperative to Integrate NGS Technology Into CNSide CSF Assay Platform
Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform
Overview
52-week range
$2.90
$24
5% of range
Avg surprise (last 3)
-50.3%
Avg reaction (last 2)
-4.4%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-1.05 | $-0.95 | -10.5% | -87.5% | -8.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.04 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.01 | $-0.09 | +88.9% | — | — | earnings |
| Fri May 30, 2025 | Mar/2025 | $-0.56 | $-0.17 | -229.4% | — | 0.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.37 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.71 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.75 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.00 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.59 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | -$0.96 | -$0.25 | -284.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | — | $1M | $1M | $1M | — | $1M | $1M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-7M | — | $-4M | $-2M | $-4M | — | $-4M | $-4M |
| Net income | $-7M | — | $-4M | $5M | $-17M | — | $-3M | $-3M |
| EPS (diluted) | $-1.05 | — | $-0.04 | $-0.01 | $-29.86 | — | $-0.37 | $-0.71 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3M | $4M | $13M | $2M | $10M | $76,000 | $1M | $5M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $18M | $15M | $18M | $9M | $11M | $5M | $5M | $9M |
| Total assets | $20M | $16M | $19M | $10M | $12M | $7M | $7M | $11M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $8M | $12M | $14M | $7M | $36M | $16M | $12M | $19M |
| Total equity | $12M | $4M | $5M | $3M | $-24M | $-9M | $-5M | $-8M |
Implied volatility — last 90 days
No IV snapshots yet for PSTV.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.